Key result
Electrocautery-assisted AngioVac aspiration successfully clears aortic valve fibroelastomas without stroke or 1-year recurrence.
Why the study?
Papillary fibroelastomas are highly adherent to tissue and resistant to aspiration alone, and simultaneous multitumor engagement increases embolization risk during percutaneous removal of multiple aortic valve lesions.
Is sequential electrocautery-assisted percutaneous vacuum aspiration with cerebral embolic protection feasible and safe for removing multiple aortic valve papillary fibroelastomas in a nonsurgical candidate?
Case Report (n=1)
No
Is sequential electrocautery-assisted percutaneous vacuum aspiration with cerebral embolic protection feasible and safe for removing multiple aortic valve papillary fibroelastomas in a nonsurgical candidate?
Demonstrates the feasibility of sequential electrocautery-facilitated AngioVac aspiration with cerebral embolic protection for removing multiple adherent left-sided aortic valve papillary fibroelastomas in patients who decline or cannot undergo surgery.
Answers are grounded in this paper and cite their sources.
May offer percutaneous option for nonsurgical candidates; leaves open need for prospective validation before wider adoption.
OBJECTIVE: To describe a stepwise approach to electrocautery-assisted vacuum aspiration for percutaneous removal of multiple aortic valve papillary fibroelastomas (PFEs) using cerebral embolic protection. KEY STEPS: Bilateral femoral arterial access; 22-F sheath (right femoral artery) and 16-F venous cannula (left femoral vein, extracorporeal membrane oxygenation). Bilateral cerebral embolic protection deployed via right radial approach into common carotids. A 20-mm snare (JR4 catheter) encircles the aspiration cannula. Once tumor engagement is confirmed, the snare is advanced over the cannula and connected to an electrocautery generator (70 W) to sever the stalk, facilitating aspiration. Repeated sequentially, one tumor at a time, to limit embolization risk. POTENTIAL PITFALLS: Simultaneous multitumor engagement increases embolization risk, requiring single-tumor targeting. Papillary fibroelastomas are highly adherent to tissue and resistant to aspiration alone; cautery severance overcomes this. Cerebral protection must precede instrumentation of left-sided lesions. TAKE-HOME MESSAGE: Electrocautery-assisted vacuum aspiration with cerebral embolic protection is feasible approach for percutaneous removal of multiple aortic valve papillary fibroelastomas in nonsurgical candidates.
No takes yet. Share an insight, caveat, or question.
Arnold et al. (2026) conducted a case report in Multiple aortic valve papillary fibroelastomas (n=1). Electrocautery-assisted percutaneous vacuum aspiration (AngioVac with 20-mm Gooseneck snare and Sentinel cerebral embolic protection) was evaluated on Successful percutaneous removal of both aortic valve papillary fibroelastomas without recurrence or neurological deficits. Electrocautery-assisted AngioVac aspiration with cerebral protection achieved complete removal of 2 aortic valve fibroelastomas without stroke or recurrence at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: